Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity.
Leuk Res
; 116: 106819, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1783622
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Leuk Res
Year:
2022
Document Type:
Article
Affiliation country:
J.leukres.2022.106819
Similar
MEDLINE
...
LILACS
LIS